Repository logo

Subunits of human condensins are potential therapeutic targets for cancers

dc.contributor.authorWang, Hong-Zhen
dc.contributor.authorYang, Si-Han
dc.contributor.authorLi, Gui-Ying
dc.contributor.authorCao, Xudong
dc.date.accessioned2018-02-25T04:18:56Z
dc.date.available2018-02-25T04:18:56Z
dc.date.issued2018-02-20
dc.date.updated2018-02-25T04:18:56Z
dc.description.abstractAbstract The main role of condensins is to regulate chromosome condensation and segregation during cell cycles. Recently, it has been suggested in the literatures that subunits of condensin I and condensin II are involved in some human cancers. This paper will first briefly discuss discoveries of human condensins, their components and structures, and their multiple cellular functions. This will be followed by reviews of most recent studies on subunits of human condensins and their dysregulations or mutations in human cancers. It can be concluded that many of these subunits have potentials to be novel targets for cancer therapies. However, hCAP-D2, a subunit of human condensin I, has not been directly documented to be associated with any human cancers to date. This review hypothesizes that hCAP-D2 can also be a potential therapeutic target for human cancers, and therefore that all subunits of human condensins are potential therapeutic targets for human cancers.
dc.identifier.citationCell Division. 2018 Feb 20;13(1):2
dc.identifier.urihttp://dx.doi.org/10.1186/s13008-018-0035-3
dc.identifier.urihttps://doi.org/10.20381/ruor-21550
dc.identifier.urihttp://hdl.handle.net/10393/37278
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titleSubunits of human condensins are potential therapeutic targets for cancers
dc.typeJournal Article

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail ImageThumbnail Image
Name:
13008_2018_Article_35.pdf
Size:
816.45 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail ImageThumbnail Image
Name:
license.txt
Size:
4.92 KB
Format:
Item-specific license agreed upon to submission
Description: